Coronavirus update

Important information:
All on-campus visits and events are cancelled or postponed until further notice. Virtual events will be running as normal unless otherwise stated.  For the latest updates visit our coronavirus information page. Please note that some of our on campus events may be replaced by virtual events - please check with the event organiser listed against each event.

MDS PERCAT Masterclass: Introduction to Enterprise and Innovation

Medical School IBR Seminar Room
Engineering and Physical Sciences, Lectures Talks and Workshops, Medical and Dental Sciences, Research
Tuesday 4th December 2018 (12:00-13:00)
Download the date to your calendar (.ics file)

To register for this event please contact Lesley Bodenham

Professor Roy Bicknell,  Director of Enterprise and Head of PERCAT, MDS and Jodie Albutt, Head of IP, Catapult Gene and Cell Therapy

Bridging Research and IP exploitation
Vicky Kosti (MSc, LL.M), MDS UoB Technology Transfer Officer, European Patent Attorney

 This Masterclass will use a new cancer target as an example to explain the process of protecting basic research by securing IPR.  It will also explain how IPR can be exploited and commercialised.

Roy and Jodie will present on their experience. There will be opportunities to ask questions and to reflect on how participants might identify opportunities for securing IPR in relation to their own research.

 Jodie Albutt has over 17 years of experience working with IP and has been the patent attorney and Head of IP at the Cell and Gene Therapy Catapult for over 3 years.  Previously, she worked in private practice for 14 years as a senior associate patent attorney.   She has particular experience in patentability assessment, drafting patent applications, patent application prosecution, and defending/attacking recently granted patents through Opposition at the European Patent Office.  Further, she has significant experience in carrying out patent portfolio due diligence, freedom to operate/patent validity assessment and advising on commercial strategies.  Her recent expertise relates to technologies within the cell and gene therapy field, but she has previously worked in many different technological areas within the life sciences.   She works on a daily basis with scientists in-house at the Cell and Gene Therapy Catapult, with scientists within academia, and with UK biotech companies.


Culture and collections

Schools, institutes and departments

Services and facilities